| Ross P Hartling, MD | |
|
330 S. Stilllaguamish Avenue, Arlington, WA 98223 | |
| (425) 649-7540 | |
| (425) 649-7548 |
| Full Name | Ross P Hartling |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 43 Years |
| Location | 330 S. Stilllaguamish Avenue, Arlington, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316950413 | NPI | - | NPPES |
| 8144081 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD00242931 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bellevue Medical Imaging, Pllc | 3375535669 | 2 |
News Archive
An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.
GOP presidential hopeful Mitt Romney continues to confront issues about the similarities between the health reform he signed while Massachusetts governor and the 2010 federal health law. Meanwhile, The Associated Press reports about some of Romney's potential running mates and key issues in the campaign.
Young women who took the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs, according to a study published in the April 29, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.
› Verified 4 days ago
| Entity Name | Bellevue Medical Imaging, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063606309 PECOS PAC ID: 3375535669 Enrollment ID: O20040330000496 |
News Archive
An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.
GOP presidential hopeful Mitt Romney continues to confront issues about the similarities between the health reform he signed while Massachusetts governor and the 2010 federal health law. Meanwhile, The Associated Press reports about some of Romney's potential running mates and key issues in the campaign.
Young women who took the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs, according to a study published in the April 29, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ross P Hartling, MD Po Box 6725, Bellevue, WA 98008-0725 Ph: (425) 649-7540 | Ross P Hartling, MD 330 S. Stilllaguamish Avenue, Arlington, WA 98223 Ph: (425) 649-7540 |
News Archive
An advanced imaging technique has revealed that some U.S. military personnel with mild blast-related traumatic brain injuries have abnormalities in the brain that have not been seen with other types of imaging.
GOP presidential hopeful Mitt Romney continues to confront issues about the similarities between the health reform he signed while Massachusetts governor and the 2010 federal health law. Meanwhile, The Associated Press reports about some of Romney's potential running mates and key issues in the campaign.
Young women who took the commonly used epilepsy drug phenytoin for one year showed significant bone loss compared to women taking other epilepsy drugs, according to a study published in the April 29, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.
Sanofi and Regeneron Pharmaceuticals, Inc. announced results from Phase 2b trials in rheumatoid arthritis (RA) and ankylosing spondylitis (AS) with sarilumab, a novel, high-affinity, subcutaneously administered, fully-human antibody targeting the interleukin-6 receptor.
› Verified 4 days ago
Kristin Ruth Grant, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 330 S Stillaguamish Ave, Department Of Radiology, Arlington, WA 98223 Phone: 360-618-7614 |